Text Size

Diagnosis of Cancer Using Breath Samples

This study has been completed.
Sponsor:
Collaborator:
Rambam Hospital
Information provided by:
Technion, Israel Institute of Technology
ClinicalTrials.gov Identifier:
NCT01234987
First received: November 3, 2010
Last updated: October 27, 2011
Last verified: December 2010
History of Changes
  Purpose

The purpose of this study is to collect breath samples from healthy and cancer sick patients. The breath, collected to special bags, will be transferred to laboratories in the Technion and analyzed using an electronic nose system developed in Hossam Haick's labs (Chemical Engineering, Technion). The hypothesis is that based on the analysis of the chemical bio-markers present in the exhaled breath, cancer states can be distinguished from healthy subjects or before and after treatment, allowing a technique for diagnosis of cancer and/or cancer treatment.


Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Diagnosis of Cancer Using Breath Samples

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Technion, Israel Institute of Technology:

Groups/Cohorts
Breast cancer
Colon cancer
Lung Cancer

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

People that undergo screening for breast, colon or lung cancers people diagnosed with breast, colon or lung cancers

Criteria

Inclusion Criteria:

  • The cancer is local or homeostatic
  • The subject did not undergo surgery for tumor removal, chemotherapy or radiation treatment prior to first sampling
  • The subject signed an informed consent form

Exclusion Criteria:

  • The subject is addicted to drugs or alcohol
  • The subject smoked in the last hour
  • There are communication problems with the subject
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01234987

Locations
Israel
Rambam Health Care Campus
Haifa, Israel, 31096
Sponsors and Collaborators
Technion, Israel Institute of Technology
Rambam Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01234987     History of Changes
Other Study ID Numbers: DCHHSGCTIL
Study First Received: November 3, 2010
Last Updated: October 27, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Technion, Israel Institute of Technology:
Cancer
Breast Cancer
Colon cancer
Lung Cancer

ClinicalTrials.gov processed this record on May 19, 2013